EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Glycosylation of Serum IgG Antibodies in Post-COVID-19 and Post-Vaccination Patients

Csaba Váradi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Csaba Váradi. Beteiligte Einrichtung: Institute of Chemistry, Faculty of Materials and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary. Hauptthemen laut MEDLINE: Immunoglobulin G, COVID-19, Antibodies, Viral, COVID-19 Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Academy of Sciences, János Bolyai Research Scholarship of the Hungarian Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The signature of human serum IgG glycosylation is critical in the defense against pathogens. Alterations of IgG N-glycome were associated with COVID-19 (Coronavirus disease 2019) severity, although knowledge on the response to vaccination is limited. IgG N-glycome was analyzed in this study in post-COVID-19 and post-vaccination patients to reveal potential glycosylation-based alterations using hydrophilic interaction liquid chromatography (HILIC-UPLC) with fluorescence (FLR) and mass-spectrometric (MS) detection. IgG antibodies were purified from serum samples through protein G affinity chromatography followed by PNGase F digestion-based deglycosylation. The released glycans were fluorescently derivatized by procainamide labeling and purified via solid-phase extraction. Higher levels of sialylation and afucosylation were identified in post-COVID-19 patients, which was further expanded by vaccination, but only in those who were previously SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) infected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GCOVID-19Antibodies, ViralCOVID-19 VaccinesHumansGlycosylationSARS-CoV-2VaccinationMiddle AgedFemaleMalePolysaccharidesAgedAdultGlycoproteins

Stichwörter der Autor:innen

COVID-19antibody glycosylationliquid chromatographyvaccination

Substanzen

Immunoglobulin GAntibodies, ViralCOVID-19 VaccinesPolysaccharidesglycosylated IgGGlycoproteins

Autor:innen und Institutionen

  • Institute of Chemistry, Faculty of Materials and Chemical Engineering, University of Miskolc, 3515 Miskolc, Hungary.

ORCID-Profile: Csaba Váradi

Förderung

  • Hungarian Academy of Sciences
  • János Bolyai Research Scholarship of the Hungarian Academy of Sciences

Zitieren

APA

Váradi, C. (2025). The Glycosylation of Serum IgG Antibodies in Post-COVID-19 and Post-Vaccination Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020807

Vancouver

Váradi C. The Glycosylation of Serum IgG Antibodies in Post-COVID-19 and Post-Vaccination Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020807

BibTeX
@article{Vradi2025,
  author = {Váradi, Csaba},
  title = {The Glycosylation of Serum IgG Antibodies in Post-COVID-19 and Post-Vaccination Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020807}
}
Kostenlos starten →